The challenge of controllable chemical synthesis of aluminum nanocrystals (Al NCs) has been met with only limited success. A major barrier is the absence of effective ligands to control the nucleation and growth of Al NCs.Here we demonstrate the size-and shape-controlled synthesis of monodisperse Al NCs using a polymer ligand, cumyl dithiobenzoate-terminated polystyrene (CDTB-PS). Density functional theory (DFT) calculations indicate that CDTB-PS shows selective absorption on Al{100} facets, inducing the formation of nanocubes and trigonal bipyramids. An excess of CDTB-PS, however, decreases the supersaturation of Al atoms, leading to the formation of {111} facetterminated octahedral and triangular plates. The concentration of the catalyst, titanium (IV) isopropoxide, determines the size of Al NCs by controlling the number of seeds. Depending on nanoparticle size, the solutions of Al NCs possess distinct colors, a characteristic feature of plasmonic nanomaterials. This robust and controlled chemical synthesis of Al NCs lays a foundation for Al as a sustainable plasmonic material for current and future applications.

We study the influence of shape of Janus particles on their orientation and surface activity at fluid-fluid interfaces via molecular dynamics simulations. The Janus particles are characterized by two regions with different wettability divided along their major axes. Three types of Janus particles are considered: Janus spheres, Janus rods, and Janus disks. We find that Janus spheres and Janus rods prefer one orientation at the interface, regardless of the surface property. In contrast, Janus disks can adopt one of two orientations when adhered to a fluid-fluid interface: one orientation corresponds to the equilibrium state and the other is a kinetically trapped metastable state. The orientation of Janus disks strongly depends on the disk characteristics, such as their size, aspect ratio, and surface property. Furthermore, we find that changes in the shape of Janus particles strongly influence the interfacial tension at the fluid-fluid interface. According to the time evolution of the interfacial tension, the adsorption of Janus particles is characterized by three adsorption stages based on different surface activities and adsorption kinetics depending on the particle shape.

Multimetallic oxygen evolution reaction (OER) electrocatalysts have recently gained significant attention due to their excellent intrinsic activity resulting from the synergistic interplay between multiple metal sites. However, in these multimetallic catalyst systems, the function of their bridging anionic ligands (e.g., O 2− , S 2− , and P 3− /PO 4 3− ) is rarely investigated, partially due to the lack of an ideal material model system. Herein, by combining a careful electrochemical conversion of metal−organic framework (MOF) precursors with low-temperature phosphorization processes, we designed a series of NiFe-based model catalysts as a proof-of-concept platform to identify the roles of different anionic ligands in tuning the redox and electronic properties of metal sites. Our experimental and theoretical results reveal that ligands having varying electron-withdrawing/donating ability can modulate not only the electron density of Ni 2+ /Fe 3+ centers but also the electron transfer efficiency from Ni 2+ to neighboring Fe 3+ sites. Importantly, synergistically coupled ligands (e.g., S 2− and PO 4 3− ) with complementary electronic properties help to optimize the chemical environments of the Ni 2+ /Fe 3+ centers (even upon partial catalyst surface reconstruction to NiFe oxyhydroxide), thus giving rise to a remarkable OER activity. These insights open new avenues for developing highly active multimetallic OER electrocatalysts.

We have developed a multiscale model that combines first-principles methods with atomistic and mesoscopic simulations to explore the molecular structures and packing density of the ligands present on the gold nanoparticle (AuNP) surface, as well as the adsorption/exchange reaction kinetics of cetyltrimethylammonium bromide (CTAB)/PEG-SH ligands on different facets of gold, namely, Au(111), Au(100), and Au(110). Our model predicts that on clean gold surfaces, CTAB adsorption is diffusion limited. Specifically, CTAB has the preferentially higher adsorption rate and coverage density on Au(100) and Au(110) surfaces, forming a more compact layer with respect to that on the Au(111) surface, which could result in greater growth of gold nanoparticles along the (111) direction. As opposed to CTAB adsorption, the exchange reaction between PEG-SH with CTAB shows no selectivity to different crystal faces, and the reaction process follows Langmuir diffusion kinetics. Kinetic analysis reveals that, in water, the exchange reaction is zeroth order with respect to the concentration of an incoming PEG-SH, indicative of a dissociative exchange mechanism. The observed rate constant decreases exponentially with the PEG-SH chain length, consistent with a diffusion process for the free PEG-SH in water. In particular, we show that the exchange efficiency increases as the chain rigidness and size of the incoming ligand and/or steric bulk of the initial protecting ligand shell are decreased. Our objectives are to provide a model to assess the kinetics and thermodynamics of the adsorption/exchange reaction process, and we expect that these findings will have important implications for routine surface characterization of AuNPs.

No abstract

No abstract

No abstract

The aim of this study was to explore the use of urantide as an antagonist of the urotensin II (UII) receptor, G protein-coupled receptor 14 (GPR14), to protect against atherosclerosis (AS) in rats. The AS rat model was induced by an intraperitoneal injection of vitamin D3 (VD3) into rats fed with a high-fat diet for four weeks. Urantide was then injected into the rats. Immunohistochemical staining, serum biochemical assay, reverse transcription-polymerase chain reaction (RT-PCR) and western blotting were used to investigate the expression of UII and its receptor GPR14 in the AS rat model. Four weeks after induction, pathological changes typical of AS were observed in the AS rat model. In the plaques of the aortic tunica intima and tunica media, expression of UII and GPR14 was observed. The protein and gene expression levels of UII and GPR14 in the model group were significantly increased compared with those in the normal group (P<0.01). Urantide ameliorated the pathological changes of AS in the rat model and reduced the gene and protein expression levels of UII and GPR14 (P<0.05 or P<0.01). UII is associated with AS and the UII receptor GPR14-specific antagonist, urantide, demonstrates the ability to protect against AS. Thus, this study provides new insight and experimental theories for the clinical application of urantide to treat AS.